Mutations that alter use of hepatitis C virus cell entry factors mediate escape from neutralizing antibodies

Gastroenterology

Volumn 143, Issue 1, 2012, Pages

  Fofana, Isabel ^a,b   Fafi Kremer, Samira ^a,b   Carolla, Patric ^a,b   Fauvelle, Catherine ^a,b   Zahid, Muhammad Nauman ^a,b   Turek, Marine ^a,b   Heydmann, Laura ^a,b   Cury, Karine ^a,b   Hayer, Juliette ^c   Combet, Christophe ^c   Cosset, François Loïc ^d   Pietschmann, Thomas ^e   Hiet, Marie Sophie ^f   Bartenschlager, Ralf ^f   Habersetzer, François ^a,b   Doffoël, Michel ^a,b   Keck, Zhen Yong ^g   Foung, Steven K H ^g   Zeisel, Mirjam B ^a,b   Stoll Keller, Françoise ^a,b   Baumert, Thomas F ^a,b   more..

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c UNIVERSITÉ DE LYON   (France)

^d UNIVERSITÉ LYON 1   (France)

^e INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Immunity; Liver Disease; Tissue Culture Model; Virology

Indexed keywords

CD81 ANTIGEN; NEUTRALIZING ANTIBODY;

ADULT; AGED; ARTICLE; CELL CULTURE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LIVER GRAFT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; VIRUS ENTRY;

EID: 84862737528     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.04.006     Document Type: Article

References (53)

1. H. Alter Viral hepatitis Hepatology 43 2006 S230 S234
2. W.P. Hofmann, S. Zeuzem A new standard of care for the treatment of chronic HCV infection Nat Rev Gastroenterol Hepatol 8 2011 257 264
3. K. Watt, B. Veldt, M. Charlton A practical guide to the management of HCV infection following liver transplantation Am J Transplant 9 2009 1707 1713
4. M.B. Zeisel, F.L. Cosset, T.F. Baumert Host neutralizing responses and pathogenesis of hepatitis C virus infection Hepatology 48 2008 299 307
5. M.B. Zeisel, I. Fofana, S. Fafi-Kremer HCV entry into hepatocytes: mechanism and potential therapeutic implications J Hepatol 54 2011 566 576
6. D. Lavillette, Y. Morice, G. Germanidis Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection J Virol 79 2005 6023 6034
7. K.A. Dowd, D.M. Netski, X.H. Wang Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus Gastroenterology 136 2009 2377 2386
8. S. Fafi-Kremer, I. Fofana, E. Soulier Enhanced viral entry and escape from antibody-mediated neutralization are key determinants for hepatitis C virus re-infection in liver transplantation J Exp Med 207 2010 2019 2031
9. Z.Y. Keck, S.H. Li, J. Xia Mutations in hepatitis C virus E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivity J Virol 83 2009 6149 6160
10. J.M. Pestka, M.B. Zeisel, E. Blaser Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C Proc Natl Acad Sci U S A 104 2007 6025 6030
11. T. von Hahn, J.C. Yoon, H. Alter Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo Gastroenterology 132 2007 667 678
12. W.O. Osburn, B.E. Fisher, K.A. Dowd Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection Gastroenterology 138 2010 315 324
13. J. Lupberger, M.B. Zeisel, F. Xiao EGFR and EphA2 are hepatitis C virus host entry factors and targets for antiviral therapy Nat Med 17 2011 589 595
14. Z. Stamataki, J. Grove, P. Balfe Hepatitis C virus entry and neutralization Clin Liver Dis 12 2008 693 712
15. C. Kuiken, C. Combet, J. Bukh A comprehensive system for consistent numbering of HCV sequences, proteins and epitopes Hepatology 44 2006 1355 1361
16. A. Haberstroh, E.K. Schnober, M.B. Zeisel Neutralizing host responses in hepatitis C virus infection target viral entry at postbinding steps and membrane fusion Gastroenterology 135 2008 1719 1728
17. K.G. Hadlock, R.E. Lanford, S. Perkins Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes J Virol 74 2000 10407 10416
18. S. Haid, M.P. Windisch, R. Bartenschlager Mouse-specific residues of claudin-1 limit hepatitis C virus genotype 2a infection in a human hepatocyte cell line J Virol 84 2009 964 975
19. G. Koutsoudakis, E. Herrmann, S. Kallis The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells J Virol 81 2007 588 598
20. B. Bartosch, J. Dubuisson, F.L. Cosset Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes J Exp Med 197 2003 633 642
21. M.B. Zeisel, G. Koutsoudakis, E.K. Schnober Scavenger receptor BI is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81 Hepatology 46 2007 1722 1731
22. I. Fofana, S.E. Krieger, F. Grunert Monoclonal anti-claudin 1 antibodies for prevention of hepatitis C virus infection Gastroenterology 139 2010 953 964 964.e1-4
23. S.E. Krieger, M.B. Zeisel, C. Davis Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations Hepatology 51 2010 1144 1157
24. G. Koutsoudakis, A. Kaul, E. Steinmann Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses J Virol 80 2006 5308 5320
25. A. Owsianka, A.W. Tarr, V.S. Juttla Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein J Virol 79 2005 11095 11104
26. E. Dazert, C. Neumann-Haefelin, S. Bressanelli Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune response J Clin Invest 119 2009 376 386
27. L. Uebelhoer, J.H. Han, B. Callendret Stable cytotoxic T cell escape mutation in hepatitis C virus is linked to maintenance of viral fitness PLoS Pathog 4 2008 e1000143
28. A.M. Owsianka, J.M. Timms, A.W. Tarr Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding J Virol 80 2006 8695 8704
29. T. Krey, J. d'Alayer, C.M. Kikuti The disulfide bonds in glycoprotein E2 of hepatitis C virus reveal the tertiary organization of the molecule PLoS Pathog 6 2010 e1000762
30. Z.Y. Keck, A. Op De Beeck, K.G. Hadlock Hepatitis C virus E2 has three immunogenic domains containing conformational epitopes with distinct properties and biological functions J Virol 78 2004 9224 9232
31. F. Helle, A. Goffard, V. Morel The neutralizing activity of anti-hepatitis C virus antibodies is modulated by specific glycans on the E2 envelope protein J Virol 81 2007 8101 8111
32. H.E. Drummer, I. Boo, A.L. Maerz A conserved gly436-trp-leu-ala-gly-leu- phe-tyr motif in hepatitis C virus glycoprotein E2 is a determinant of CD81 binding and viral entry J Virol 80 2006 7844 7853
33. I. Boo, K. Tewierek, F. Douam Distinct roles in folding, CD81 receptor binding and viral entry for conserved histidines of HCV glycoprotein E1 and E2 Biochem J 443 2012 85 94
34. R. Roccasecca, H. Ansuini, A. Vitelli Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2 J Virol 77 2003 1856 1867
35. K. McCaffrey, I. Boo, P. Poumbourios Expression and characterization of a minimal hepatitis C virus glycoprotein E2 core domain that retains CD81 binding J Virol 81 2007 9584 9590
36. H.J. Harris, C. Davis, J.G. Mullins Claudin association with CD81 defines hepatitis C virus entry J Biol Chem 285 2010 21092 21102
37. M. Law, T. Maruyama, J. Lewis Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge Nat Med 14 2008 25 27
38. T. Vanwolleghem, J. Bukh, P. Meuleman Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver-chimeric mice from infection with a homologous hepatitis C virus strain Hepatology 47 2008 1846 1855
39. M. Rychlowska, A.M. Owsianka, S.K. Foung Comprehensive linker-scanning mutagenesis of the hepatitis C virus E1 and E2 envelope glycoproteins reveals new structure-function relationships J Gen Virol 92 2011 2249 2261
40. S. Fafi-Kremer, I. Fofana, E. Soulier Enhanced viral entry and escape from antibody-mediated neutralization are key determinants for hepatitis C virus re-infection in liver transplantation J Exp Med 207 2010 2019 2031
41. J.M. Pestka, M.B. Zeisel, E. Blaser Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C Proc Natl Acad Sci U S A 104 2007 6025 6030
42. S.E. Krieger, M.B. Zeisel, C. Davis Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations Hepatology 51 2010 1144 1157
43. T. Pietschmann, A. Kaul, G. Koutsoudakis Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras Proc Natl Acad Sci U S A 103 2006 7408 7413
44. A. Kaul, I. Woerz, P. Meuleman Cell culture adaptation of hepatitis C virus and in vivo viability of an adapted variant J Virol 81 2007 13168 13179
45. Y. Wang, Z.Y. Keck, A. Saha Affinity maturation to improve human monoclonal antibody neutralization potency and breadth against hepatitis C virus J Biol Chem 286 2011 44218 44233
46. C. Combet, N. Garnier, C. Charavay euHCVdb: the European hepatitis C virus database Nucleic Acids Res 35 2007 D363 D366
47. A. Owsianka, A.W. Tarr, V.S. Juttla Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein J Virol 79 2005 11095 11104
48. A. Haberstroh, E.K. Schnober, Zeisel Neutralizing host responses in hepatitis C virus infection target viral entry at postbinding steps and membrane fusion Gastroenterology 135 2008 1719 1728
49. K.G. Hadlock, R.E. Lanford, S. Perkins Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes J Virol 74 2000 10407 10416
50. Z.Y. Keck, S.H. Li, J. Xia Mutations in hepatitis C virus E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivity J Virol 83 2009 6149 6160
51. M. Dimitrova, C. Affolter, F. Meyer Sustained delivery of siRNAs targeting viral infection by cell-degradable multilayered polyelectrolyte films Proc Natl Acad Sci U S A 105 2008 16320 16325
52. J. Lupberger, M.B. Zeisel, F. Xiao EGFR and EphA2 are hepatitis C virus host entry factors and targets for antiviral therapy Nat Med 17 2011 589 595
53. B. Bartosch, A. Vitelli, C. Granier Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor J Biol Chem 278 2003 41624 41630